白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2009年
4期
210-212
,共3页
吴瞳%李增军%王亚非%邹德慧%齐军元%邱录贵
吳瞳%李增軍%王亞非%鄒德慧%齊軍元%邱錄貴
오동%리증군%왕아비%추덕혜%제군원%구록귀
白血病,淋巴细胞,慢性%并发症%预后
白血病,淋巴細胞,慢性%併髮癥%預後
백혈병,림파세포,만성%병발증%예후
Leukemia,lymphocytic,chronic%Complication%Prognosis
目的 探讨慢性淋巴细胞白血病(CLL)患者并发症的临床特点.方法 回顾性分析就诊于中国医学科学院血液病医院并获得有效随访的203例CLL患者并发症的临床表现及其预后价值.结果 40例(19.7%)患者发生部位明确的感染,最常见感染部位为肺部(75.6%).15例(7.4%)患者发生自身免疫性疾病(AID),最常见的AID为自身免疫性溶血性贫血(AIHA)(31.3%).8例(3.94%)患者并发第二肿瘤,包括肺癌等多种肿瘤.3例(1.48%)患者发生类型转化,其中,2例向幼淋巴细胞门血病(PLL)转化,1例向弥漫大B细胞淋巴瘤(DLBCL)转化(Richter综合征).预后分析显示并发感染、第二肿瘤或转化与不良预后有关,并发AID与预后无明显相关.结论 CLL患者常见并发症包括感染、AID、第二肿瘤或转化,其中,以肺部感染及AIHA最为常见,未见明显高发的第二肿瘤类型.并发感染、并发第二肿瘤或转化为不良预后因素.
目的 探討慢性淋巴細胞白血病(CLL)患者併髮癥的臨床特點.方法 迴顧性分析就診于中國醫學科學院血液病醫院併穫得有效隨訪的203例CLL患者併髮癥的臨床錶現及其預後價值.結果 40例(19.7%)患者髮生部位明確的感染,最常見感染部位為肺部(75.6%).15例(7.4%)患者髮生自身免疫性疾病(AID),最常見的AID為自身免疫性溶血性貧血(AIHA)(31.3%).8例(3.94%)患者併髮第二腫瘤,包括肺癌等多種腫瘤.3例(1.48%)患者髮生類型轉化,其中,2例嚮幼淋巴細胞門血病(PLL)轉化,1例嚮瀰漫大B細胞淋巴瘤(DLBCL)轉化(Richter綜閤徵).預後分析顯示併髮感染、第二腫瘤或轉化與不良預後有關,併髮AID與預後無明顯相關.結論 CLL患者常見併髮癥包括感染、AID、第二腫瘤或轉化,其中,以肺部感染及AIHA最為常見,未見明顯高髮的第二腫瘤類型.併髮感染、併髮第二腫瘤或轉化為不良預後因素.
목적 탐토만성림파세포백혈병(CLL)환자병발증적림상특점.방법 회고성분석취진우중국의학과학원혈액병의원병획득유효수방적203례CLL환자병발증적림상표현급기예후개치.결과 40례(19.7%)환자발생부위명학적감염,최상견감염부위위폐부(75.6%).15례(7.4%)환자발생자신면역성질병(AID),최상견적AID위자신면역성용혈성빈혈(AIHA)(31.3%).8례(3.94%)환자병발제이종류,포괄폐암등다충종류.3례(1.48%)환자발생류형전화,기중,2례향유림파세포문혈병(PLL)전화,1례향미만대B세포림파류(DLBCL)전화(Richter종합정).예후분석현시병발감염、제이종류혹전화여불량예후유관,병발AID여예후무명현상관.결론 CLL환자상견병발증포괄감염、AID、제이종류혹전화,기중,이폐부감염급AIHA최위상견,미견명현고발적제이종류류형.병발감염、병발제이종류혹전화위불량예후인소.
Objective To summarize the common complications of chronic lymphocytic leukemia (CLL). Methods 203 cases of CLL patients from the Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, were retrospectively reviewed and followed up.The common complications of CLL were also summarized. Survival analysis was used to analyze the prognostic value of these common complications. Results 40 (19.7 %) patients sustained infectious complications,and the respiratory tract infections were the most common type (75.6 %). 15 (7.4 %) patients complicated with autoimmune diseases (AID), and the autoimmune hemolytic anemia(AIHA) were the most common type(31.3%). 8(3.94 %) patients suffered from secondary cancers, including lung cancer, etc.3(1.48 %) patients developed other high-grade lymphomas, 2 of them transformed to prolymphocytic leukemia (PLL), 1 of them transformed to diffuse large B cell lymphoma (DLBCL) which was called Richter syndrome. Complicating infections and secondary cancers or transformations were associated with poor prognosis.Complicating AIDs was not an adverse prognostic factor. Conclusion Infections, AIDs and secondary cancers or transformations are common complications of CLL patients.Lung is the most common infectious site, and AIHA is the most common AID type,none secondary cancer s incidence rate is specifically higher than the others. Infections and secondary cancers or transformations indicate poor prognosis.